Answers are grounded in this paper and cite their sources.
Retrospective study evaluates contrast-induced nephropathy in stroke imaging, indicating increased risks in CKD patients.
Rationale Contrast-induced nephropathy (CIN) is a known cause of hospital-acquired acute kidney injury (AKI), especially in patients with pre-existing chronic kidney disease (CKD). While modern low-osmolality contrast agents have reduced associated risks, CIN remains clinically significant, resulting in increased morbidity and prolonged hospitalization. This study evaluated the incidence and clinical outcomes of CIN following stroke imaging with iodinated contrast among patients with and without CKD. Methods A retrospective chart review was conducted including adult patients who received 100 mL of low-osmolality iodinated contrast (iopamidol) during neuroimaging over 12 months. CIN was defined as a ≥ 25% increase in serum creatinine or an absolute rise of ≥ 0.5 mg/dL within 48-72 hours post-exposure. Patients were categorized into CKD (eGFR <60 mL/min/1.73 m²) and non-CKD (eGFR ≥60 mL/min/1.73 m²) groups. Incidence of CIN, relative risk (RR), and hospital outcomes including need for dialysis, ICU admission, and length of stay were analyzed. Results Among 545 patients, 134 (24.6%) had CKD. CIN developed in 27 of 134 CKD patients (20.1%) versus 18 of 411 non-CKD patients (4.4%), representing a more than four-fold increased risk in the CKD group (RR = 4.57; 95% CI: 2.56-8.16). The mean rise in serum creatinine among patients with CIN was 0.6 mg/dL in the CKD group versus 0.3 mg/dL in the non-CKD group. Renal function recovered without dialysis in all cases. However, patients who developed CIN experienced longer median hospital stays (8 vs. 5 days, p < 0.05) and higher rates of ICU admission and in-hospital complications, including fluid overload and electrolyte imbalance. No CIN-related mortality occurred. Conclusion CIN was significantly more frequent among CKD patients despite the use of low-osmolality contrast. Though reversible, CIN was associated with increased resource utilization and adverse clinical outcomes. Risk stratification and adherence to preventive protocols remain critical in minimizing CIN among vulnerable patients.
No takes yet. Share an insight, caveat, or question.
Saeedi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: